IGM Biosciences Inc at Bank of America Global Healthcare Conference Transcript
Welcome to day 1 of the Bank of America Healthcare Conference. I'm Greg Harrison, one of the biotech analysts here at BofA. And today, we have IGM Biosciences with us. And from IGM, we have Fred Schwarzer, Chief Executive Officer. Thanks for joining us, Fred.
Thanks for having us. I appreciate it.
Maybe you'd like to start off with a couple of opening remarks, and then we can jump into Q&A.
Sure. I guess I probably would focus on the 2 most important programs in our pipeline that we at least -- the programs are the furthest along right now, and the first would be our Death Receptor 5 program, where we showed some really interesting data we thought at -- in January at a competitor's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
